Multipotency of equine mesenchymal stem cells derived from synovial fluid.
Authors: Murata D, Miyakoshi D, Hatazoe T, Miura N, Tokunaga S, Fujiki M, Nakayama K, Misumi K
Journal: Veterinary journal (London, England : 1997)
Summary
# Editorial Summary: Multipotency of Equine Mesenchymal Stem Cells Derived from Synovial Fluid Regenerative cell therapy offers genuine promise for managing intra-articular fractures and osteochondritis dissecans in performance horses, particularly when combined with arthroscopic intervention, yet sourcing suitable cell populations has remained challenging. Murata and colleagues isolated mesenchymal stromal cells from synovial fluid harvested from horses with joint injury and inflammation, then characterised their multipotency through flow cytometry analysis and differentiation assays across multiple lineages. The researchers successfully expanded SF-derived cells to clinically relevant numbers (>10⁷ cells by passage four) and demonstrated robust expression of classic mesenchymal markers (>90% positive for CD44, CD90 and MHC class I), whilst crucially confirming these were not contaminating haematopoietic cells (CD34 and CD45 negative). Under appropriate culture conditions, the cells reliably differentiated into osteogenic, chondrogenic, adipogenic and tenogenic phenotypes, with chondrogenic induction producing characteristic morphological changes and intense Alcian blue staining of cartilage matrix. This work is significant for equine practitioners because it establishes synovial fluid—readily accessible via arthrocentesis during joint surgery—as a viable source of autologous multipotent stem cells, potentially eliminating the need for more invasive tissue harvesting and enabling same-procedure cell therapy protocols that could improve healing outcomes in career-limiting joint injuries.
Read the full abstract on PubMed
Practical Takeaways
- •Synovial fluid from horses with joint injuries contains multipotent mesenchymal stem cells that can be expanded in culture for potential cell therapy applications
- •These SF-derived cells demonstrate the ability to differentiate into cartilage-producing chondrocytes, offering a promising regenerative approach for articular cartilage defects in racehorses
- •This technique provides a minimally invasive source of autologous stem cells from existing joint pathology that could support post-arthroscopic cartilage regeneration
Key Findings
- •Mesenchymal stromal cells isolated from synovial fluid of horses with joint injury reached >1×10^7 cells by fourth passage
- •SF-derived cells expressed high levels of CD44, CD90, and MHC class I (>90%) and were negative for CD34 and CD45
- •SF-derived cells successfully differentiated into osteogenic, chondrogenic, adipogenic, and tenogenic lineages under specific culture conditions
- •Chondrogenic differentiation produced gelatinous sheets intensely stained with Alcian blue, indicating cartilage matrix formation